Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$737M |
| 2 |
Invesco S&P 500 Revenue ETF
RWL
|
+$669M |
| 3 |
Bank of America
BAC
|
+$513M |
| 4 |
Amazon
AMZN
|
+$510M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$482M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco S&P 500 Pure Value ETF
RPV
|
+$491M |
| 2 |
Trade Desk
TTD
|
+$466M |
| 3 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$373M |
| 4 |
Eli Lilly
LLY
|
+$367M |
| 5 |
Williams-Sonoma
WSM
|
+$295M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.41% |
| 2 | Financials | 13.31% |
| 3 | Industrials | 11.28% |
| 4 | Healthcare | 10.55% |
| 5 | Consumer Discretionary | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3651
Veru
VERU
$35.5M
| $30.4K | ﹤0.01% |
6,196
-282
| -4% | -$1.75K |
|
3652
Paysign
PAYS
$523M
| $30.2K | ﹤0.01% |
14,226
-599
| -4% | -$1.6K |
|
3653
Rekor Systems
REKR
$83M
| $29.9K | ﹤0.01% |
33,748
-1,143
| -3% | -$1.8K |
|
3654
Prime Medicine
PRME
$535M
| $29.5K | ﹤0.01% |
14,836
-235
| -2% | -$599 |
|
3655
Vuzix
VUZI
$179M
| $29K | ﹤0.01% |
14,235
-5,525
| -28% | -$18.1K |
|
3656
TScan Therapeutics
TCRX
$48.7M
| $28.4K | ﹤0.01% |
20,590
-38
| -0.2% | -$82 |
|
3657
ProKidney
PROK
$314M
| $28.3K | ﹤0.01% |
32,258
+135
| +0.4% | +$187 |
|
3658
Traeger
COOK
$162M
| $26.5K | ﹤0.01% |
315
+111
| +54% | +$12.3K |
|
3659
Lineage Cell Therapeutics
LCTX
$259M
| $26.2K | ﹤0.01% |
58,038
-3,747
| -6% | -$2.2K |
|
|
FRGE
3660
DELISTED
Forge Global Holdings
FRGE
| $25.8K | ﹤0.01% |
3,063
-120
| -4% | -$1.39K |
|
|
APLT
3661
DELISTED
Applied Therapeutics
APLT
| $25K | ﹤0.01% |
51,098
-2,401
| -4% | -$1.41K |
|
3662
Pyxis Oncology
PYXS
$188M
| $24.3K | ﹤0.01% |
24,805
-561
| -2% | -$748 |
|
3663
ProQR Therapeutics
PRQR
$243M
| $24.1K | ﹤0.01% |
18,084
+6,197
| +52% | +$13.2K |
|
3664
BRC Inc
BRCC
$123M
| $24K | ﹤0.01% |
11,487
-958
| -8% | -$2.44K |
|
3665
LiveOne
LVO
$60.6M
| $23.4K | ﹤0.01% |
3,350
+13
| +0.4% | +$128 |
|
3666
Biomea Fusion
BMEA
$88.9M
| $23.3K | ﹤0.01% |
10,959
-649
| -6% | -$2.21K |
|
|
NOTE
3667
DELISTED
FiscalNote
NOTE
| $21.9K | ﹤0.01% |
2,257
-97
| -4% | -$1.46K |
|
|
KG
3668
Kestrel Group
KG
$66.3M
| $21.5K | ﹤0.01% |
1,886
-70
| -4% | -$1.32K |
|
|
FLNA
3669
Filana Therapeutics
FLNA
$42M
| $19.7K | ﹤0.01% |
13,117
-2,291
| -15% | -$5.78K |
|
3670
Tevogen Bio Holdings
TVGN
$23.2M
| $19.2K | ﹤0.01% |
356
+16
| +5% | +$1.05K |
|
3671
Inovio Pharmaceuticals
INO
$83.1M
| $19.2K | ﹤0.01% |
11,779
-258
| -2% | -$518 |
|
3672
GrowGeneration
GRWG
$86.5M
| $19K | ﹤0.01% |
17,608
-877
| -5% | -$1.18K |
|
3673
Shattuck Labs
STTK
$642M
| $18K | ﹤0.01% |
18,908
+182
| +1% | +$224 |
|
|
INZY
3674
DELISTED
Inozyme Pharma
INZY
| $17.6K | ﹤0.01% |
19,315
-592
| -3% | -$821 |
|
|
LNAI
3675
Lunai Bioworks
LNAI
$9.84M
| $15.9K | ﹤0.01% |
366
+3
| +0.8% | +$192 |
|
Similar funds
Invesco's Q1 2025 Portfolio in Review
As of Q1 2025, Invesco held 3,856 positions worth $528B, down 2.4% from $541B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Invesco's Q1 2025 filing shows 117 new, 1,793 increased, 1,749 reduced and 89 closed positions. Its largest new stake was Invesco Managed Futures Strategy ETF: 4,184,000 shares worth $206M. The largest sale was Invesco S&P 500 Pure Value ETF, an estimated $491M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Financials and Industrials.
- Invesco's largest Q1 2025 buy was Invesco Managed Futures Strategy ETF: 4,184,000 shares worth $206M.
- Invesco added most to Tesla in Q1 2025, an estimated $737M increase.
- Invesco's biggest Q1 2025 reduction was Invesco S&P 500 Pure Value ETF, cutting an estimated $491M.
- Invesco fully exited ENLINK MIDSTREAM, LLC in Q1 2025, selling an estimated $281M.
- Invesco's ten largest holdings make up 17% of its $528B portfolio in Q1 2025.
- Invesco opened 117 new positions and closed 89 in Q1 2025.
- Invesco's portfolio value fell 2.4% quarter-over-quarter to $528B.
Based on Invesco's 13F filing for Q1 2025, filed 12 May 2025.